MEPSGEN Co.
Latest round
- Series C
Last raised
- Nov 2024
Total raised
- $17M
Investors
- 8
About MEPSGEN Co.
, Ltd., Ltd. operates from Seoul, South Korea, focusing on innovative platforms for drug development.MEPSGEN specializes in advanced drug development platforms, offering innovative solutions through its core product lines: ProMEPS™, MEPS-X series, and NanoCalibur™. ProMEPS™ provides a robust framework for pharmaceutical companies, focusing on enhancing the efficiency and effectiveness of drug discovery processes. The MEPS-X series is designed to optimize the microfluidic handling of compounds, significantly reducing development time and costs. NanoCalibur™ targets micro and nano-scale applications, catering to the pharmaceutical industry's need for precision in drug formulation and delivery systems.MEPSGEN generates revenue primarily through direct sales and partnerships with pharmaceutical companies and research institutions. Transactions typically involve the sale of its flagship products, including ProMEPS™ and NanoCalibur™, structured as one-time purchases or as part of subscription-based service agreements for ongoing support and updates. The pricing structure reflects the specialized nature of these products, with costs aligned to the value provided in accelerating drug development timelines and improving efficacy. MEPSGEN’s client engagements often entail customized solutions tailored to specific research needs, fostering long-term relationships within the B2B sector., Ltd. MEPSGEN plans to expand into additional markets across Europe and North America by 2025, leveraging its innovative platforms to address the evolving needs of the pharmaceutical sector.
Who invested in MEPSGEN Co.
8 investors across 2 rounds
See all investors in MEPSGEN Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MEPSGEN Co.
Who invested in MEPSGEN Co.?
MEPSGEN Co. has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MEPSGEN Co. raised?
MEPSGEN Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did MEPSGEN Co. last raise money?
MEPSGEN Co.'s most recent round on record is a Series C, in Nov 2024.
What does MEPSGEN Co. do?
MEPSGEN Co. is a biotechnology company.
Where is MEPSGEN Co. headquartered?
MEPSGEN Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like MEPSGEN Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MEPSGEN Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like MEPSGEN Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.